Aurinia Pharmaceuticals Inc (NASDAQ:AUPH): A Fundamentally Weighted Stock for Long-Term Investors
The stock of Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) last traded at $9.04, up 3.43% from the previous session. Data from the available sources indicates that Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) is covered by 8 analysts. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of […]
Does Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) have deteriorating prospects?
The stock of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) last traded at $9.82, down -7.01% from the previous session. Data from the available sources indicates that Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) is covered by 8 analysts. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of […]
When is the right time to cash out of Aurinia Pharmaceuticals Inc. [AUPH] stock?
Stocks of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) traded higher last session on Wall Street, down -0.64% to $10.87. According to the data, Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) has 8 analysts covering its stock. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $15.00 and […]
The shares of Aurinia Pharmaceuticals Inc. (AUPH) have recorded the market capitalization of 1.45B
The stock of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) last traded at $10.12, up 1.71% from the previous session. Data from the available sources indicates that Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) is covered by 8 analysts. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of […]
